This section of the GSK study register provides citations from pre-clinical research where there is a GSK author. Please note that there may be other publications that are not listed here.
To find citations, enter a key word into the Citation Text Search field and/or enter a Publication Year.
|2017||Abberley L. Outsourcing of bioanalysis at GSK: a hybrid approach with a robust support model. Bioanalysis. 2017;9(15):1139-1144.|
|2017||Abla N, Bashyam S, Charman SA, et al. Long-Lasting and Fast-Acting in Vivo Efficacious Antiplasmodial Azepanylcarbazole Amino Alcohol. ACS Med Chem Lett. 2017;8(12):1304-1308.|
|2016||Abrahams KA, Chung CW, Ghidelli-Disse S, et al. Identification of KasA as the cellular target of an anti-tubercular scaffold. Nat Commun. 2016;7:12581.|
|2017||Abrahams KA, Cox JAG, Futterer K, et al. Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface. Sci Rep. 2017;7(1):9430.|
|2016||Adams PD, Aertgeerts K, Bauer C, et al. Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop. Structure. 2016;24(4):502-508.|
|2017||Aden A, Anderson P, Burnett GR, Lynch RJ, Tomlins PH. Longitudinal correlation of 3D OCT to detect early stage erosion in bovine enamel. Biomed Opt Express. 2017;8(2):954-973.|
|2016||Aich U, Lakbub J, Liu A. State-of-the-art technologies for rapid and high-throughput sample preparation and analysis of N-glycans from antibodies. Electrophoresis. 2016;37(11):1468-1488.|
|2017||Akhtar WM, Cheong CB, Frost JR, Christensen KE, Stevenson NG, Donohoe TJ. Hydrogen Borrowing Catalysis with Secondary Alcohols: A New Route for the Generation of beta-Branched Carbonyl Compounds. J Am Chem Soc. 2017;139(7):2577-2580.|
|2016||Alamillo-Ferrer C, Karabourniotis-Sotti M, Kennedy AR, Campbell M, Tomkinson NC. Alkene Dioxygenation with Malonoyl Peroxides: Synthesis of gamma-Lactones, Isobenzofuranones, and Tetrahydrofurans. Org Lett. 2016;18(13):3102-3105.|
|2016||Alder CM, Hayler JD, Henderson RK, et al. Updating and further expanding GSK's solvent sustainability guide. Green Chemistry. 2016;18(13):3879-3890.|
|2017||Aldrich CC, Calderon F. ACS Infectious Diseases Special Issue Focused on Drug Discovery for Global Health. ACS Infect Dis. 2017;3(5):329.|
|2016||Allen DW. Phosphines and related C-P bonded compounds. In: Allen DW, Tebby JC, Loakes D, eds. Organophosphorus Chemistry. Vol 45: Royal Society of Chemistry; 2016:1-50.|
|2016||Amata E, Xi H, Colmenarejo G, et al. Identification of "Preferred" Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing? ACS Infect Dis. 2016;2(3):180-186.|
|2016||Anderson JC, Campbell IB, Campos S, et al. Reductive conjugate addition nitro-Mannich route for the stereoselective synthesis of 1,2,3,4-tetrahydroquinoxalines. Org Biomol Chem. 2016;14(35):8270-8277.|
|2017||Anderson JC, Campbell IB, Campos S, Rundell CD, Shannon J, Tizzard GJ. Base-Controlled Diastereoselective Synthesis of Either anti- or syn-beta-Aminonitriles. Org Lett. 2017;19(7):1918-1921.|
|2016||Anderson NA, Campbell IB, Fallon BJ, et al. Synthesis and determination of absolute configuration of a non-peptidic alphavbeta6 integrin antagonist for the treatment of idiopathic pulmonary fibrosis. Org Biomol Chem. 2016;14(25):5992-6009.|
|2017||Andrei SA, Sijbesma E, Hann M, et al. Stabilization of protein-protein interactions in drug discovery. Expert Opin Drug Discov. 2017;12(9):925-940.|
|2017||Angiolilli C, Kabala PA, Grabiec AM, et al. Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Ann Rheum Dis. 2017;76(1):277-285.|
|2018||Annibaldi A, Wicky John S, Vanden Berghe T, et al. Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2. Mol Cell. 2018;69(4):566-580 e565.|
|2016||Aon JC, Sun J, Leighton JM, Appelbaum ER. Hypoxia-elicited impairment of cell wall integrity, glycosylation precursor synthesis, and growth in scaled-up high-cell density fed-batch cultures of Saccharomyces cerevisiae. Microb Cell Fact. 2016;15(1):142.|
|2016||Archibald PR, Chandra A, Thomas D, et al. Comparability of automated human induced pluripotent stem cell culture: a pilot study. Bioprocess Biosyst Eng. 2016;39(12):1847-1858.|
|2016||Arico-Muendel CC. From haystack to needle: finding value with DNA encoded library technology at GSK. MedChemComm. 2016;7(10):1898-1909.|
|2017||Artois J, Blasdell K, Duong V, et al. Effects of mammarenavirus infection (Wenzhou virus) on the morphology of Rattus exulans. Infect Genet Evol. 2017.|
|2017||Athanasopoulos T, Munye MM, Yanez-Munoz RJ. Nonintegrating Gene Therapy Vectors. Hematol Oncol Clin North Am. 2017;31(5):753-770.|
|2017||Axten JM. Protein kinase R(PKR)-like endoplasmic reticulum kinase (PERK) inhibitors: a patent review (2010-2015). Expert Opin Ther Pat. 2017;27(1):37-48.|
For more information on this register please email GSKClinicalSupportHD@gsk.com
GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.
IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).
This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.
EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.